Neurofilament Light Chain Appears Promising As Prognostic Biomarker In GBS, Study Indicates

November 16, 2020

MedPage Today (11/13, George) reported, “Neurofilament light chain (NfL), a measure of axonal damage, showed promise as a prognostic biomarker in Guillain-Barré syndrome (GBS),” investigators concluded in a study that linked “high serum NfL levels in GBS...